SARS-CoV-2 research with chitosan - publications to date
The corona virus disease COVID-19 has changed the world. To combat the pandemic, researchers and companies around the world are working to develop vaccines and medicines. Chitosan also has potential in the area of vaccine development and functionalization of protective equipment such as respirators. We have prepared summaries of recent publications on chitosan as an aid in the fight against corona.
Viral safety of chitosan
What about the viral safety of chitosan? Here, we would like to present an interesting publication about the viral safety of chitosan. Chitosan can be applied as a virus-free biopolymer for medical products in human, as the deacetylation process of chitin is sufficient for virus inactivation, shown by Park et al (2015). The researchers from Korea used chitin from Heppe Medical Chitosan to show that viruses are efficiently inactivated during the deacetylation process from chitin to chitosan.
Chitosan and SARS-CoV-2
The corona virus disease COVID-19 has changed the world since early 2020 in many ways. To combat the pandemic, researchers and companies around the world develop vaccines and medicines. Chitosan has potential in the area of vaccine development and functionalization of protective equipment such as respirators. We prepared reviews of recent publications about chitosan in the fight against corona.